PBF Energy is rated Strong Buy due to surging crack spreads and a significant earnings turnaround driven by global refinery capacity cuts and rising oil prices. These factors have structurally increased profit margins, positioning PBF to generate approximately $8.5 billion in net earnings over several years. Despite some expectations of EPS declines, supply-demand imbalances are expected to sustain robust spreads and earnings at least through 2030. PBF's ability to capture a large portion of market crack spread increases supports aggressive debt reduction or capital returns to shareholders.
PBF Energy is highlighted in this market context snapshot. For readers following energy stocks, here is Pluang's market snapshot as of Sep 17, 2026 19:12 WIB: Of 30 priced US energy-sector stocks tradable on Pluang, 10 rose and 18 fell today. Notable movers include UEC at USD 10.32 with a 1-day change of +2.38% and Pluang order activity showing 5% Sell / 95% Buy, CEG at USD 264.65 up +1.97% with 11% Sell / 89% Buy, and EOG at USD 143.45 down -1.02% with 16% Sell / 84% Buy. Typical hold times range from 34 to 58 days on Pluang.
Changan Automobile announced new partnerships covering seven European markets and launched its "with U" service program at Mondial de l’Auto 2026. This marks a shift from market entry to building a local ecosystem including manufacturing, sales, serv...
At the 2026 Mondial de l’Auto, Changan Automobile signed letters of intent with eight companies across seven European markets and launched its "with U" service program. This marks a strategic move to build a strong local ecosystem combining manufactu...
Northland Power Inc. announced it will release its third quarter 2026 financial results after market close on November 12, 2026. The company will host an earnings call and webcast on November 13 at 9:00 a.m. ET, providing investors an opportunity to ...
Several daily leveraged ETFs tied to tech and crypto-related stocks dropped sharply, with declines over 20%. Notable falls include GraniteShares 2x Long NBIS Daily ETF down 24.5% and Leverage Shares 2x Long CRWV Daily ETF down 23.9%. These ETFs aim t...
Recent biotech IPOs Iambic Therapeutics and City Therapeutics saw significant price jumps, rising 25.9% and 22.2% respectively after their market debuts, raising substantial capital. Inverse leveraged ETFs SMCZ and SMST also gained sharply as their u...
